SEER*Rx - Interactive Antineoplastic Drugs Database SEER*Rx was developed as a one-step lookup for coding oncology drug and regimen treatment categories in cancer registries The information in this database is effective for cancer diagnoses made on January 1, 2005 and after
SEER Rx Interactive Antineoplastic Drugs Database-Regimen Terminology The SEER (Surveillance, Epidemiology, and End Results) program Rx Interactive Antineoplastic Drugs Database-Regimen terminology is a set of terms containing oncology drugs and regimens that are intended for coding oncology drug and regimen treatment categories in cancer registries
SEER*Rx - coderx. io SEER*Rx Interactive Antineoplastic Drugs Database SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS)
SEER*Rx Interactive Drug Database - CNET Solutions SEER*Rx Interactive Drug Database CALL (800) 366-2638 TODAY C NET Solutions Your Total Cancer Registry Solution! We believe that data is knowledge and knowledge is power Our cost-effective software provides fast and accurate cancer data acquisition, so you have the information you need to monitor treatment and improve the lives of cancer
The Florida Cancer Data System - Downloads SEER*RX Interactive Antineoplastic Drugs Database Registry Plus (on CDC website) You also download the Version 11 help file from this link Please use the appropriate Data Acquisition Manual version depending on the version of data your are submitting Use the **2024** FCDS DAM starting July 1, 2024 FCDS **2024** Data Acquisition Manual:
Training Resources | Texas DSHS National Cancer Institute, Surveillance, Epidemiology, and End Results Program (NCI-SEER) Cancer Research, Prevention, and Advocacy Organizations Texas Comprehensive Cancer Control Program (DSHS-TCCCP) Texas Breast and Cervical Cancer Services (HHS-BCCS) Cancer Prevention and Research Institute of Texas (CPRIT)
MCR-Related Manuals - University of Mississippi Medical Center Collaborative staging manual SEER coding and staging manual SEER summary page 2000 SEER*RX interactive antineoplastic drugs database Registry Plus online help Abstractor's standard abbreviations Multiple primary and histology coding manual Hematopoietic and lymphoid neoplasm database and coding manual Grade coding instructions 2014+ CNS coding
www. cancerregistryeducation. org The SEER Inquiry System (SINQ) is a searchable collection of questions that cancer registrars have had while coding cancer cases These are questions submitted by designated registrars in SEER registries
SEER*Rx Interactive Antineoplastic Drugs Database A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site (s) listed in SEER*Rx for that agent